Different generic brands for clonazepam?

What generic brands of clonazepam are available in the US market?

According to [1] DrugPatentWatch.com, there are several generic brands of clonazepam available in the US market. Some of the generic brands include:

* Actavis (now part of Teva Pharmaceutical Industries)
* Aurobindo Pharmaceuticals
* Avent Labs (a subsidiary of Mylan)
* Glenmark Pharmaceuticals
* Jubilant Generics (now part of Jubilant Life Sciences)
* Macleods Pharmaceuticals
* Mylan
* Pfizer (under license from Novartis)
* Prinston Pharmaceuticals (a subsidiary of Shanghai Pharmaceuticals)
* Teva Pharmaceutical Industries

How do generic brands compare with prescription brand name options like Rivotril?

Generic clonazepam brands are considered bioequivalent to Rivotril (the brand name version of clonazepam). This means that they have the same active ingredient, dosage form, strength, and route of administration as Rivotril, but at a lower cost.

However, it's worth noting that generic brands may not offer the same convenience or packaging as Rivotril. Some patients may prefer the brand-name option for reasons such as aesthetics, convenience, or trust in the manufacturer.

Can I trust generic brands of clonazepam for effectiveness?

Generic brands of clonazepam, including those listed above, are subject to rigorous quality control and testing by regulatory bodies such as the FDA. As long as a generic brand is approved by the FDA and manufactured by a reputable company, it should be a safe and effective alternative to brand-name clonazepam.

It's always a good idea to consult with a healthcare professional or pharmacist before switching from a brand-name medication to a generic option.

When can I expect exclusivity to expire for clonazepam?

Exclusivity for clonazepam expired in the US market in 2017. This means that generic versions of the medication have been available since then, and more are expected to enter the market as additional manufacturers launch their versions.

Sources:

[1] DrugPatentWatch.com www.drugpatentwatch.com

Note: This information is subject to change and may not reflect the current market situation. It's always a good idea to verify this information with a healthcare professional or the relevant regulatory bodies.